Singapore markets open in 8 hours 43 minutes

MAIA Biotechnology, Inc. (MAIA)

NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
3.4800+0.0400 (+1.16%)
As of 11:54AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 75.12M
Enterprise value 74.92M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)134.48
Enterprise value/revenue N/A
Enterprise value/EBITDA -2.34

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 351.54%
S&P500 52-week change 323.12%
52-week high 35.9900
52-week low 30.8200
50-day moving average 33.4016
200-day moving average 32.0737

Share statistics

Avg vol (3-month) 3364.55k
Avg vol (10-day) 3219.79k
Shares outstanding 521.84M
Implied shares outstanding 621.84M
Float 817.41M
% held by insiders 117.86%
% held by institutions 13.03%
Shares short (14 Jun 2024) 4589.96k
Short ratio (14 Jun 2024) 41.07
Short % of float (14 Jun 2024) 43.29%
Short % of shares outstanding (14 Jun 2024) 42.70%
Shares short (prior month 15 May 2024) 41.22M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-140.15%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-23.72M
Diluted EPS (ttm)-1.5700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)8.27M
Total cash per share (mrq)0.38
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)1.77
Book value per share (mrq)-0.28

Cash flow statement

Operating cash flow (ttm)-13.3M
Levered free cash flow (ttm)-8.11M